The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
IL-10 and its related cytokines for treatment of inflammatory bowel disease
Open accessAbstract
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis are chronic inflammatory disorders of gastrointestinal tract. Although the etiology is incompletely understood, initiation and aggravation of the inflammatory process seem to be due to a massive local mucosal immune response. Interleukin-10 (IL-10) is a regulatory cytokine which inhibits both antigen presentation and subsequent pro-inflammatory cytokine release, and it is proposed as a potent anti-inflammatory biological therapy in chronic IBD. Many methods of IL-10 as a treatment for IBD have been published. The new strategies of IL-10 treatment, including recombinant IL-10, the use of genetically modified bacteria, gelatine microsphere containing IL-10, adenoviral vectors encoding IL-10 and combining regulatory T cells are discussed in this review. The advantages and disadvantages of these IL-10 therapies are summarized. Although most results of recombinant IL-10 therapies are disappointing in clinical testing because of lacking efficacy or side effects, therapeutic strategies utilizing gene therapy may enhance mucosal delivery and increase therapeutic response. Novel IL-10-related cytokines, including IL-19, IL-20, IL-22, IL-24, IL-26, IL-28 and IL-29, are involved in regulation of inflammatory and immune responses. The use of IL-10 and IL-10-related cytokines will provide new insights into cell-based and gene-based treatment against IBD in near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lindsay, J. O., Ciesielski, C. J., Scheinin, T., Brennan, F. M., & Hodgson, H. J. F. (2003) · Gut · doi:10.1136/gut.52.3.363 · Cited by 73
RetractedIFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814
Blumberg, H., Conklin, D., Xu, W., Grossmann, A., Brender, T., Carollo, S., Eagan, M., Foster, D., Haldeman, B. A., Hammond, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00187-8 · Cited by 547
Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., & Remaut, E. (2003) · Nature Biotechnology · doi:10.1038/nbt840 · Cited by 542
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Control of intestinal inflammation by regulatory T cells
Singh, B., Read, S., Asseman, C., Malmström, V., Mottet, C., Stephens, L. A., Stepankova, R., Tlaskalova, H., & Powrie, F. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820115.x · Cited by 500
Dumoutier, L., Louahed, J., & Renauld, J.-C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1814 · Cited by 500
Jiang, H., Lin, J. J., Su, Z.-Z., Goldstein, N. I., & Fisher, P. B. (1995) · PubMed · Cited by 486
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
Schreiber, S., Fedorak, R. N., Nielsen, O. H., Wild, G., Williams, C. N., Nikolaus, S., Jacyna, M., Lashner, B. A., Gangl, A., Rutgeerts, P., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20196 · Cited by 458
Landers, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y., Braun, J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.35379 · Cited by 440
Donnelly, R. P., Dickensheets, H., & Finbloom, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313695 · Cited by 413
Interleukin-10 Receptor Signaling through the JAK-STAT Pathway
Riley, J. K., Takeda, K., Akira, S., & Schreiber, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16513 · Cited by 398
Biologic therapy of inflammatory bowel disease
Sandborn, W. J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33426 · Cited by 344
Gallagher, G., Dickensheets, H., Eskdale, J., Izotova, L., Mirochnitchenko, O., Peat, J., Vazquez, N., Pestka, S., Donnelly, R., & Kotenko, S. (2000) · Genes & Immunity · doi:10.1038/sj.gene.6363714 · Cited by 288
Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S. J. H., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., et al. (2002) · Gut · doi:10.1136/gut.50.2.191 · Cited by 272
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
Regulatory T cells and inflammatory bowel disease
Groux, H., & Powrie, F. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01510-8 · Cited by 258
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
Colombel, J.-F., Rutgeerts, P., Malchow, H., Jacyna, M., Nielsen, O. H., Rask-Madsen, J., Van Deventer, S., Ferguson, A., Desreumaux, P., Forbes, A., et al. (2001) · Gut · doi:10.1136/gut.49.1.42 · Cited by 240
XII. IL-10-deficient (IL-10−/−) mice and intestinal inflammation
Rennick, D. M., & Fort, M. M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g829 · Cited by 225
Knappe, A., Hör, S., Wittmann, S., & Fickenscher, H. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3881-3887.2000 · Cited by 214
Whalen, J. D., Lechman, E. L., Carlos, C. A., Weiss, K., Kovesdi, I., Glorioso, J. C., Robbins, P. D., & Evans, C. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3625 · Cited by 202
Role of IL-10 for induction of anemia during inflammation
Tilg, H., Ulmer, H., Kaser, A., & Weiss, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2204 · Cited by 181
Interleukin 10 gene transfer prevents experimental colitis in rats
Barbara, G. (2000) · Gut · doi:10.1136/gut.46.3.344 · Cited by 152
Chung, K. F., Patel, H. J., Fadlon, E., Rousell, J., Haddad, E., Jose, P. J., Mitchell, J. A., & Belvisi, M. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702660 · Cited by 99
Comparative Genomic Analysis of the Interferon/Interleukin-10 Receptor Gene ClusterPreprint
Reboul, J., Gardiner, K., Monneron, D., Uzé, G., & Lutfalla, G. (1999) · Genome Research · doi:10.1101/gr.9.3.242 · Cited by 89
IL-10 therapy in Crohn's disease: at the crossroads
Herfarth, H. H., & Schölmerich, J. (2002) · Gut · doi:10.1136/gut.50.2.146 · Cited by 77
Minter, R. M., Rectenwald, J. E., Fukuzuka, K., Tannahill, C. L., LaFace, D., Tsai, V., Ahmed, I., Hutchins, E. D., Moyer, R. W., Copeland, E. M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.443 · Cited by 72
Prevention of colitis by interleukin 10–transduced T lymphocytes in the SCID mice transfer model
van Montfrans, C., Rodríguez-Peña, M. S., Pronk, I., ten Kate, F. J. W., Velde, A. A. T., & van Deventer, S. J. H. (2002) · Gastroenterology · doi:10.1053/gast.2002.37067 · Cited by 72
Nakase, H., Okazaki, K., Tabata, Y., Ozeki, M., Watanabe, N., Ohana, M., Uose, S., Uchida, K., Nishi, T., Mastuura, M., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.59 · Cited by 67
Wirtz, S. J., Galle, P. R., & Neurath, M. F. (1999) · Gut · doi:10.1136/gut.44.6.800 · Cited by 59
The immunoregulatory cytokine interleukin‐10—a therapy for Crohn’s disease?
Lindsay, J. O., & Hodgson, H. J. F. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01093.x · Cited by 54
IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes
Ebert, E. C. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01147.x · Cited by 41
Ishizuka, K., Sugimura, K., Homma, T., Matsuzawa, J., Mochizuki, T., Kobayashi, M., Suzuki, K., Otsuka, K., Tashiro, K., Yamaguchi, O., et al. (2001) · Digestion · doi:10.1159/000051906 · Cited by 40
Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer
van Montfrans, C., Hooijberg, E., Rodríguez-Peña, M. S., de Jong, E. C., Spits, H., Velde, A. A. T., & van Deventer, S. J. H. (2002) · Gastroenterology · doi:10.1053/gast.2002.37066 · Cited by 40
Chirmule, N. B., Truneh, A., Haecker, S. E., Tazelaar, J., Gao, G., Raper, S. E., Hughes, J. V., & Wilson, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.448 · Cited by 38
Recombinant interleukin 10 for the treatment of active Crohn's disease: Lessons in biologic therapy
Bickston, S. J., & Cominelli, F. (2000) · Gastroenterology · doi:10.1053/gast.2000.20822 · Cited by 23
Current medical therapy of inflammatory bowel disease.
Das, K. M., & Farag, S. A. (2000) · PubMed Central · doi:10.3748/wjg.v6.i4.483 · Cited by 22
Combining T cells and IL-10: A new therapy for Crohn's disease?
Madsen, K. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.37289 · Cited by 19
Sasaki, M., Jordan, P., Houghton, J., Meng, X., Itoh, M., Joh, T., & Alexander, J. S. (2003) · BMC Gastroenterology · doi:10.1186/1471-230x-3-3 · Cited by 18
Okazaki, K., Nakase, H., Watanabe, N., Tabata, Y., Ikada, Y., & Chiba, T. (2002) · Journal of Gastroenterology · doi:10.1007/bf03326413 · Cited by 16
New treatments for inflammatory bowel disease
Rampton, D. S. (1998) · World Journal of Gastroenterology · doi:10.3748/wjg.v4.i5.369 · Cited by 9
Cited by
Immunological pathogenesis of inflammatory bowel disease
Lee, S. H., Kwon, J. E., & Cho, M.-L. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.1.26 · Cited by 575
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diepolder, H., Marquardt, A., Jagla, W., Popp, A., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00513.2005 · Cited by 549
The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis
Steen, E. H., Wang, X., Balaji, S., Butte, M. J., Bollyky, P. L., & Keswani, S. G. (2020) · Advances in Wound Care · doi:10.1089/wound.2019.1032 · Cited by 433
Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 402
Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease
Mirsepasi-Lauridsen, H. C., Vallance, B. A., Krogfelt, K. A., & Petersen, A. M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-18 · Cited by 359
Metadata
- Authors
- Li, M.-C.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2004
- Volume
- 10
- Issue
- 5
- Pages
- 620
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W72719101
- Cited by
- 277
- References
- 46
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.